May 23 (Reuters) - CohBar Inc CWBR.O :
* COHBAR, INC. AND MORPHOGENESIS, INC. ENTER INTO DEFINITIVE
MERGER AGREEMENT TO ADVANCE AN INNOVATIVE LATE-STAGE CLINICAL
IMMUNO-ONCOLOGY PIPELINE OF THERAPIES TO OVERCOME RESISTANCE TO
CANCER IMMUNOTHERAPY
* COHBAR INC - COMBINED COMPANY WILL OPERATE UNDER NAME
"TUHURA
BIOSCIENCES, INC."
* COHBAR INC - $15 MILLION PIPE FINANCING TO CLOSE
CONCURRENT WITH
CLOSING OF PROPOSED MERGER - COMBINED COMPANY EXPECTED TO HAVE
CASH RUNWAY THROUGH 2024
Source text for Eikon: ID:nGNXVCjF3
Further company coverage: CWBR.O
((reuters.briefs@thomsonreuters.com;))